Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Rhoen Klinikum AGLTS:0NQH 72 ROC (Joel Greenblatt) % is 7.44% as of Jun. 2026, which is 17% above its 10-year median of 6.36. GuruFocus rates LTS:0NQH with a GF Score™ of 72/100 and a GF Value™ of €13.42 (Fairly Valued). The stock has 7 warning signs investors should review. Among 669 Healthcare Providers & Services companies, Rhoen Klinikum AG ranks worse than 57.55% on this metric.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Rhoen Klinikum AG's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2026 was 7.44%.
The historical rank and industry rank for Rhoen Klinikum AG's ROC (Joel Greenblatt) % or its related term are showing as below:
LTS:0NQH'
s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 1.31 Med: 6.36 Max: 14.31
Current: 7.76
During the past 13 years, Rhoen Klinikum AG's highest ROC (Joel Greenblatt) % was 14.31%. The lowest was 1.31%. And the median was 6.36%.
LTS:0NQH's ROC (Joel Greenblatt) % is ranked worse than 57.55% of 669
companies
in the Healthcare Providers & Services industry
Industry Median: 12.73
vs LTS:0NQH: 7.76
Rhoen Klinikum AG's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was 35.10% per year.
Rhoen Klinikum AG (LTS:0NQH) ROC (Joel Greenblatt) % Explanation
The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.
Rhoen Klinikum AG ROC (Joel Greenblatt) % Related Terms
Rhoen Klinikum AG ROC (Joel Greenblatt) % Historical Data
* Premium members only.
The historical data trend for Rhoen Klinikum AG's ROC (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LTS:0NQH vs HCA, THC, DVA: ROC (Joel Greenblatt) % Comparison
For the Medical Care Facilities subindustry, Rhoen Klinikum AG's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Rhoen Klinikum AG ROC (Joel Greenblatt) % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Rhoen Klinikum AG's ROC (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where Rhoen Klinikum AG's ROC (Joel Greenblatt) % falls into.
Rhoen Klinikum AG ROC (Joel Greenblatt) % Calculation
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:
EBIT stands for Earnings Before Interest and Taxes.
Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.
GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.
Note:
The EBIT data used here is four times the quarterly (Jun. 2026) EBIT data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROC (Joel Greenblatt) % of 7.44% mean?
Rhoen Klinikum AG (LTS:0NQH) has a ROC (Joel Greenblatt) % of 7.44% as of Jun. 2026. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Rhoen Klinikum AG and its competitors. This is 17% above median its historical median of 6.36. Over the past decade, Rhoen Klinikum AG's ROC (Joel Greenblatt) % has ranged from 1.31 to 14.31. According to the industry distribution chart, Rhoen Klinikum AG ranks #385 out of 669 companies in the Healthcare Providers & Services industry, placing it in the top 57.5%.
Is Rhoen Klinikum AG's ROC (Joel Greenblatt) % too high?
Rhoen Klinikum AG's current ROC (Joel Greenblatt) % of 7.44% is 17% above median its 10-year median of 6.36. Over the past 10 years, this metric has ranged from a low of 1.31 to a high of 14.31. The Healthcare Providers & Services industry median ROC (Joel Greenblatt) % is 12.73. Rhoen Klinikum AG's value of 7.44% is 41.6% below this industry median. Based on the distribution chart, Rhoen Klinikum AG ranks #385 out of 669 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Rhoen Klinikum AG has a GF Score™ of 72/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Rhoen Klinikum AG's ROC (Joel Greenblatt) % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Rhoen Klinikum AG ranks #385 out of 669 companies for ROC (Joel Greenblatt) %. This places Rhoen Klinikum AG in the lower half of its industry. The industry median ROC (Joel Greenblatt) % is 12.73. Rhoen Klinikum AG's value of 7.44% is 41.6% below this benchmark. Historically, Rhoen Klinikum AG's own ROC (Joel Greenblatt) % has ranged from 1.31 to 14.31 over the past decade. While the company's 10-year median is 6.36 vs. the industry median of 12.73, Rhoen Klinikum AG has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Healthcare Providers & Services company?
The median ROC (Joel Greenblatt) % among Healthcare Providers & Services companies is 12.73, based on 669 companies in the industry. Companies in the top quartile (top 25%) have a ROC (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Rhoen Klinikum AG's current ROC (Joel Greenblatt) % of 7.44% is 41.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Rhoen Klinikum AG and its competitors. For the Healthcare Providers & Services industry, the median ROC (Joel Greenblatt) % is 12.73 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Rhoen Klinikum AG's current ROC (Joel Greenblatt) % is 7.44%, which is 17% above median its own 10-year median of 6.36. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rhoen Klinikum AG stock overvalued right now?
Based on GuruFocus' analysis, Rhoen Klinikum AG (LTS:0NQH) is currently considered Fairly Valued. The stock's GF Value™ is €13.42, compared to a current price of €14.60 — trading 8.8% above its estimated fair value. The current ROC (Joel Greenblatt) % is 7.44%, which is 17% above median its 10-year median of 6.36 and 41.6% below the Healthcare Providers & Services industry median of 12.73. Rhoen Klinikum AG's overall GF Score™ is 72/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For Rhoen Klinikum AG (LTS:0NQH), the current ROC (Joel Greenblatt) % is 7.44% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Rhoen Klinikum AG (LTS:0NQH) Overvalued in 2026?
Based on GuruFocus' analysis, Rhoen Klinikum AG stock appears to be overvalued.
The current stock price of €14.60 is trading 8.8% above its estimated GF Value™ of €13.42.
GuruFocus considers Rhoen Klinikum AG to be Fairly Valued.
Key valuation signals for LTS:0NQH:
ROC (Joel Greenblatt) %: 7.44% (17% above median its 10-year median of 6.36)
GF Value™: €13.42 vs. price of €14.60 (8.8% above fair value)
Industry Position: 41.6% below the Healthcare Providers & Services median (#385 of 669)
No single metric tells the full story. See the LTS:0NQH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Rhoen Klinikum AG provides medical care and healthcare services. The firm operates in three business areas: acute hospitals, medical care centers, and rehabilitation hospitals. The acute hospitals business contributes to the vast majority of the firm's overall revenue. The majority of patients at the firm's acute hospitals and medical care centers are treated on inpatient, semi-inpatient and outpatient healthcare basis. The company generates the entire revenue in Germany, with the Bavaria and Hesse regions contributing the majority proportions of revenue.
72GF Score
Get the complete analysis for LTS:0NQH
ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0NQH has been successfully added to your 
